UBS reiterates Buy on Procter & Gamble stock ahead of earnings
UBS reiterated a Buy rating on Procter & Gamble (PG) with a $172.00 price target, expecting Q1 2027 EPS of $1.85, below consensus. UBS notes improving U.S. consumption trends and expects PG to meet fiscal 2027 sales growth outlook despite cost pressures. PG trades at a P/E of 24.02 with a 2.77% dividend yield. Evercore ISI upgraded PG to Outperform, raising its Q1 2027 organic sales growth estimate to 3%. Moody’s affirmed PG’s Aa3 rating with a positive outlook.
How this was made
The 30-second read
Why it matters
The rating and target could attract short-term buying ahead of the earnings release.
Market read
Analyst upgrade adds modest bullish bias to PG ahead of its earnings report.
What to watch
Potential cost pressures and the pending earnings guidance range could temper upside.
Background
UBS analysts expect PG to report EPS of $1.85, slightly below consensus, but see improving consumption trends.
Ticker impact
UBS reiterated a Buy rating on Procter & Gamble and set a $172 price target ahead of its Q1 fiscal 2027 earnings release on Oct 22.
likely upward pressure as the market prices in the upgraded rating and target.
UBS’s buy rating and $172 target are new analyst actions that can move the stock before earnings.
Market effects
Consumer staples may see modest rally as a major player receives a fresh buy rating.
U.S. market sentiment could improve slightly in the consumer goods segment.
Limited to U.S. equities; no direct global macro effect.
Counterpoint
The upgrade may be premature if inflation pressures erode margins before earnings.
Key entities
- companyProcter & Gamble Co.
Consumer goods conglomerate, ticker PG.
- analystUBS
Investment bank providing the buy rating and price target.



